Basilicata Lab
Genes, Chromatin and Rare Neurodevelopmental Disorders
Genes, Chromatin and Rare Neurodevelopmental Disorders
Our team investigates the complex interplay between genetic alterations, cellular homeostasis, and biological sex in rare neurodevelopmental disorders. We employ multidisciplinary approaches to understand disease mechanisms and identify potential therapeutic and diagnostic strategies for conditions with no interventional protocols.
Using human disease models, we study how seemingly unrelated genetic changes ultimately lead to similar developmental bottlenecks, often through adaptive mechanisms such as paralogue compensation and metabolic rewiring. We aim to develop treatments that target these shared effects rather than each individual genetic ‘entry point’.
Collectively 58 million people worldwide are diagnosed with rare neurodevelopmental disorders leading to intellectual disability and failure to thrive. The most enriched class of causative mutations are found in genes belonging to the chromatin machinery, exemplified by the Basilicata-Akhtar syndrome (MRXSBA). We explore how chromatin factors extend beyond their gene-regulating roles to affect processes outside the nucleus.
We study how biological sex influences embryonic development and disease progression through both genetic and hormonal mechanisms. We aim to develop more personalized approaches to treating disorders that account for sex specific differences in pathophysiology.
| Name | Position | |
|---|---|---|
| Basilicata, M. Felicia | felicia.basilicata | Assistant Professor of Molecular Generegulation |
| Engelhardt, Verena | verena.engelhardt | Postdoc |
| Villard, Melanie | melanie.villard | Research Technician |